[HTML][HTML] Noninvasive biomarkers of liver fibrosis: an overview

HI Fallatah - Advances in Hepatology, 2014 - hindawi.com
Chronic liver diseases of differing etiologies are among the leading causes of mortality and
morbidity worldwide. Establishing accurate staging of liver disease is very important for …

[HTML][HTML] Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

G Sebastiani, A Alberti - World journal of gastroenterology: WJG, 2006 - ncbi.nlm.nih.gov
Chronic liver diseases are very common worldwide, particularly those linked to viral hepatitis
and to alcoholic and non-alcoholic fatty liver. Their natural history is variable and long-term …

[HTML][HTML] Non-invasive markers of liver fibrosis: adjuncts or alternatives to liver biopsy?

JL Chin, M Pavlides, A Moolla, JD Ryan - Frontiers in pharmacology, 2016 - frontiersin.org
Liver fibrosis reflects sustained liver injury often from multiple, simultaneous factors. Whilst
the presence of mild fibrosis on biopsy can be a reassuring finding, the identification of …

Circulating markers of liver fibrosis progression

P Jarčuška, M Janičko, E Veselíny, P Jarčuška… - Clinica Chimica …, 2010 - Elsevier
INTRODUCTION: Fibrogenesis is a typical reaction of the liver to injury. In the case of
overstimulation of fibrogenesis clinically significant fibrosis and, eventually, cirrhosis occur …

[HTML][HTML] Noninvasive biomarkers of liver fibrosis: clinical applications and future directions

DL Motola, P Caravan, RT Chung, BC Fuchs - Current pathobiology …, 2014 - Springer
Chronic liver disease is a significant cause of morbidity and mortality worldwide. Current
strategies for assessing prognosis and treatment rely on accurate assessment of disease …

Non-invasive assessment of liver fibrosis: it is time for laboratory medicine

G Sebastiani, K Gkouvatsos, M Plebani - Clinical chemistry and …, 2011 - degruyter.com
Chronic liver diseases (CLDs) represent a major cause of morbidity and mortality worldwide.
In all etiologies of CLDs, staging of liver fibrosis is essential for both prognosis and …

[HTML][HTML] Non-invasive markers for hepatic fibrosis

A Baranova, P Lal, A Birerdinc, ZM Younossi - BMC gastroenterology, 2011 - Springer
With great advancements in the therapeutic modalities used for the treatment of chronic liver
diseases, the accurate assessment of liver fibrosis is a vital need for successful …

Non-invasive diagnosis and monitoring of liver fibrosis and cirrhosis

UW Denzer, S Lüth - Best practice & research Clinical gastroenterology, 2009 - Elsevier
The accurate staging of liver fibrosis in chronic liver diseases, especially the early diagnosis
of liver cirrhosis, is crucial for prognostic assessment of the course of the disease. The …

[HTML][HTML] Clinical importance of laboratory biomarkers in liver fibrosis

G Aleknavičiūtė-Valienė, V Banys - Biochemia Medica, 2022 - hrcak.srce.hr
Sažetak Hepatic cirrhosis is a major health problem across the world, causing high morbidity
and mortality. This disease has many etiologies, yet the result of chronic hepatic injury is …

[PDF][PDF] Non-invasive assessment of liver fibrosis using serum markers

EA Saad - J Pharm Chem Biol Sci, 2014 - academia.edu
Fibrosis is an intrinsic response to chronic injury, that elicits excess deposition of matrix
compounds and scarring, which ultimately alters liver structure and function. Liver biopsy …